Hollings Renton
Director/Board Member at ANAPTYSBIO, INC.
Net worth: - $ as of 2024-03-30
Profile
Hollings Chase Renton is currently the Lead Independent Director at AnaptysBio, Inc., the Director at Zymeworks BC, Inc., and the Independent Director at Zymeworks, Inc. Previously, he held positions such as Chairman, President & Chief Executive Officer at Onyx Pharmaceuticals, Inc., Chairman at Portola Pharmaceuticals LLC, Independent Director at Rigel Pharmaceuticals, Inc., Director at CEPHEID, and President & Chief Operating Officer at Chiron Corp.
He also served as a Director at SangStat Medical Corp., Genzyme Corp., Kythera Biopharmaceuticals LLC, Biotechnology Innovation Organization, Affymax, Inc., and Special Olympics of Northern California.
Mr. Renton obtained an undergraduate degree from Colorado State University and an MBA from the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ANAPTYSBIO, INC.
-.--% | 2024-01-02 | 0 ( -.--% ) | - $ | 2024-03-30 |
ZYMEWORKS INC.
-.--% | 2023-10-10 | 0 ( -.--% ) | - $ | 2024-03-30 |
Hollings Renton active positions
| Companies | Position | Start |
|---|---|---|
| ANAPTYSBIO, INC. | Director/Board Member | 2015-06-29 |
| ZYMEWORKS INC. | Director/Board Member | 2017-01-31 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Director/Board Member | 2017-02-02 |
Former positions of Hollings Renton
| Companies | Position | End |
|---|---|---|
| PORTOLA PHARMACEUTICALS, INC. | Chairman | 2020-06-30 |
| CEPHEID | Director/Board Member | 2016-10-31 |
| KYTHERA BIOPHARMACEUTICALS INC | Director/Board Member | 2015-09-30 |
| AFFYMAX, INC. | Chairman | 2013-06-10 |
| RIGEL PHARMACEUTICALS, INC. | Director/Board Member | 2014-03-29 |
Training of Hollings Renton
| Colorado State University | Undergraduate Degree |
| University of Michigan | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| ANAPTYSBIO, INC. | Health Technology |
| AFFYMAX, INC. | Health Technology |
| Private companies | 12 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
| SangStat Medical Corp. | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
CEPHEID
 CEPHEID Medical SpecialtiesHealth Technology CEPHEID develops, manufactures and markets fully-integrated systems that perform genetic analysis. The firm's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company was founded by Thomas L. Gutshall, William McMillan, Kurt Petersen, Greg Kovacs and M. Allen Northrup on March 4, 1996 and is headquartered in Sunnyvale, CA. | Health Technology |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
| Cetus Corp. | Health Technology |
| Special Olympics of Northern California | |
| Zymeworks, Inc. |
- Stock Market
- Insiders
- Hollings Renton
